Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag

PHASE2CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

January 31, 2015

Study Completion Date

March 31, 2015

Conditions
Thrombocytopaenia
Interventions
DRUG

Eltrombopag olamine

thrombopoietin receptor agonist

OTHER

Placebo

Placebo tablets with no active pharmaceutical ingredient

Trial Locations (86)

4

GSK Investigational Site, Dublin

7

GSK Investigational Site, Dublin

24

GSK Investigational Site, Tallaght, Dublin

1529

GSK Investigational Site, Budapest

3000

GSK Investigational Site, Leuven

5000

GSK Investigational Site, Namur

6000

GSK Investigational Site, Charleroi

6800

GSK Investigational Site, Libramont

7400

GSK Investigational Site, Kaposvár

8900

GSK Investigational Site, Zalaegerszeg

9022

GSK Investigational Site, Győr

10367

GSK Investigational Site, Berlin

12206

GSK Investigational Site, Albany

14169

GSK Investigational Site, Berlin

19096

GSK Investigational Site, Wynnewood

19106

GSK Investigational Site, Philadelphia

20133

GSK Investigational Site, Milan

20817

GSK Investigational Site, Bethesda

20850

GSK Investigational Site, Rockville

23502

GSK Investigational Site, Norfolk

27403

GSK Investigational Site, Greensboro

29605

GSK Investigational Site, Greenville

30165

GSK Investigational Site, Rome

30171

GSK Investigational Site, Hanover

31405

GSK Investigational Site, Savannah

32256

GSK Investigational Site, Jacksonville

33081

GSK Investigational Site, Aviano (PN)

33520

GSK Investigational Site, Tampere

34362

GSK Investigational Site, Haifa

34655

GSK Investigational Site, New Port Richey

38642

GSK Investigational Site, Goslar

41100

GSK Investigational Site, Modena

44281

GSK Investigational Site, Kfar Saba

45122

GSK Investigational Site, Essen

56126

GSK Investigational Site, Pisa

64239

GSK Investigational Site, Tel Aviv

65201

GSK Investigational Site, Columbia

67214

GSK Investigational Site, Wichita

70300

GSK Investigational Site, Zrifin

71100

GSK Investigational Site, Heraklion, Crete

71913

GSK Investigational Site, Hot Springs

75246

GSK Investigational Site, Dallas

75702

GSK Investigational Site, Tyler

76014

GSK Investigational Site, Arlington

76022

GSK Investigational Site, Bedford

78217

GSK Investigational Site, San Antonio

78306

GSK Investigational Site, Ashkelon

78731

GSK Investigational Site, Austin

79106

GSK Investigational Site, Freiburg im Breisgau

80335

GSK Investigational Site, Munich

81241

GSK Investigational Site, Munich

86150

GSK Investigational Site, Augsburg

86336

GSK Investigational Site, Sedona

89169

GSK Investigational Site, Las Vegas

91031

GSK Investigational Site, Jerusalem

91730

GSK Investigational Site, Rancho Cucamonga

97701

GSK Investigational Site, Bend

98026

GSK Investigational Site, Edmonds

98405

GSK Investigational Site, Tacoma

98684

GSK Investigational Site, Vancouver

98902

GSK Investigational Site, Yakima

411001

GSK Investigational Site, Pune

411004

GSK Investigational Site, Pune

625107

GSK Investigational Site, Madurai

06360

GSK Investigational Site, Norwich

08003

GSK Investigational Site, Cherry Hill

02903

GSK Investigational Site, Providence

02906

GSK Investigational Site, Providence

T6G 1Z2

GSK Investigational Site, Edmonton

M5G 2M9

GSK Investigational Site, Toronto

775 20

GSK Investigational Site, Olomouc

100 00

GSK Investigational Site, Prague

150 06

GSK Investigational Site, Prague

00290

GSK Investigational Site, Helsinki

01127

GSK Investigational Site, Dresden

01307

GSK Investigational Site, Dresden

115 27

GSK Investigational Site, Athens

115 28

GSK Investigational Site, Athens

564 29

GSK Investigational Site, Thessaloniki

Unknown

GSK Investigational Site, Törökbálint

07100

GSK Investigational Site, Sassari

15-540

GSK Investigational Site, Bialystok

62-500

GSK Investigational Site, Konin

10-357

GSK Investigational Site, Olsztyn

60-569

GSK Investigational Site, Poznan

61-866

GSK Investigational Site, Poznan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY